{"id":14834,"date":"2018-09-10T17:27:05","date_gmt":"2018-09-10T17:27:05","guid":{"rendered":"https:\/\/drugprevent.org.uk\/ppp\/?p=14834"},"modified":"2020-01-14T19:01:38","modified_gmt":"2020-01-14T19:01:38","slug":"fda-federal-register-submission-for-who-review-and-consideration-genotoxicity-teratogenicity-concise-2","status":"publish","type":"post","link":"https:\/\/drugprevent.org.uk\/ppp\/2018\/09\/fda-federal-register-submission-for-who-review-and-consideration-genotoxicity-teratogenicity-concise-2\/","title":{"rendered":"FDA Federal Register Submission for WHO Review and Consideration &#8211; Genotoxicity Teratogenicity Concise 2"},"content":{"rendered":"<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\">Response by Prof. Stuart Reece to FDA<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14844 size-full\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-01-e1575921419615.png\" alt=\"\" width=\"673\" height=\"1024\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14845 size-full\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-02-e1575921460190.png\" alt=\"\" width=\"739\" height=\"1024\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14846 size-full\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-03-e1575921480408.png\" alt=\"\" width=\"777\" height=\"1024\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14847\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-04.png\" alt=\"\" width=\"499\" height=\"434\" srcset=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-04.png 998w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-04-300x261.png 300w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-04-768x667.png 768w\" sizes=\"auto, (max-width: 499px) 100vw, 499px\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14848\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-05.png\" alt=\"\" width=\"429\" height=\"317\" srcset=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-05.png 979w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-05-300x222.png 300w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-05-768x567.png 768w\" sizes=\"auto, (max-width: 429px) 100vw, 429px\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14849\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-06.png\" alt=\"\" width=\"427\" height=\"565\" srcset=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-06.png 581w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-06-227x300.png 227w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-06-768x1016.png 768w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-06-774x1024.png 774w\" sizes=\"auto, (max-width: 427px) 100vw, 427px\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14850\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-07.png\" alt=\"\" width=\"421\" height=\"578\" srcset=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-07.png 560w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-07-219x300.png 219w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-07-768x1053.png 768w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-07-747x1024.png 747w\" sizes=\"auto, (max-width: 421px) 100vw, 421px\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14851\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-08.png\" alt=\"\" width=\"441\" height=\"609\" srcset=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-08.png 556w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-08-217x300.png 217w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-08-768x1061.png 768w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-08-742x1024.png 742w\" sizes=\"auto, (max-width: 441px) 100vw, 441px\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-14852\" src=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-09.png\" alt=\"\" width=\"450\" height=\"338\" srcset=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-09.png 1007w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-09-300x225.png 300w, https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2-09-768x576.png 768w\" sizes=\"auto, (max-width: 450px) 100vw, 450px\" \/><\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\">Link to FDA<\/span><\/p>\n<p style=\"text-align: justify\"><a href=\"https:\/\/www.federalregister.gov\/documents\/2018\/04\/09\/2018-07225\/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\">https:\/\/www.federalregister.gov\/documents\/2018\/04\/09\/2018-07225\/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic<\/span><\/a><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\">Source: Dr Stuart Reece&#8217;s original response letter to the FDA:<\/span><\/p>\n<p style=\"text-align: justify\"><span style=\"font-family: verdana, geneva, sans-serif;font-size: 10pt;color: #0000ff\"><a style=\"color: #0000ff\" href=\"https:\/\/drugprevent.org.uk\/ppp\/wp-content\/uploads\/2018\/09\/03-FDA-Federal-Register-Submission-for-WHO-Review-and-Consideration-Genotoxicity-Teratogenicity-Concise-2.pdf\">03 FDA Federal Register Submission for WHO Review and Consideration &#8211; Genotoxicity Teratogenicity Concise 2<\/a>\u00a0 April 2018<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Response by Prof. Stuart Reece to FDA Link to FDA https:\/\/www.federalregister.gov\/documents\/2018\/04\/09\/2018-07225\/international-drug-scheduling-convention-on-psychotropic-substances-single-convention-on-narcotic Source: Dr Stuart Reece&#8217;s original response letter to the FDA: 03 FDA Federal Register Submission for WHO Review and Consideration &#8211; Genotoxicity Teratogenicity Concise 2\u00a0 April 2018<\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[30,41,25,104],"tags":[],"class_list":["post-14834","post","type-post","status-publish","format-standard","hentry","category-cannabis-marijuana","category-drug-use-effects-on-foetus","category-law","category-political-sector"],"_links":{"self":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/14834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/comments?post=14834"}],"version-history":[{"count":0,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/posts\/14834\/revisions"}],"wp:attachment":[{"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/media?parent=14834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/categories?post=14834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/drugprevent.org.uk\/ppp\/wp-json\/wp\/v2\/tags?post=14834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}